European Medicines Agency
Version 5 (Lot/Exp removed and published as Appendix IV to the PI templates)
07/2004
USE IN SUMMARY OF PRODUCT CHARACTERISTICS
FULL TERM |
EN |
DA |
DE |
EL |
ES |
FI |
FR |
IT |
NL |
PT |
SV |
NO |
IS |
angiotensin converting enzyme |
ACE |
√ |
√ |
ΜΕΑ |
ECA |
√ |
IEC |
√ |
√ |
IECA |
√ |
√ |
√ |
deoxyribonucleic acid |
DNA |
√ |
DNS or DNA |
√ |
√ |
√ |
ADN |
√ |
√ |
ADN |
√ |
√ |
√ |
monoamine oxidase inhibitors |
MAOI |
√ |
MAO-Hemmer |
αναστολείς ΜΑΟ |
IMAO |
MAO-estäjä |
IMAO |
IMAO |
MAO-remmers |
IMAO |
MAO - hämmare |
MAO - hemmere |
MAO - hemill |
volume of distribution |
Vd |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
activated partial thromboplastin time |
aPTT |
X |
√ |
X |
X |
√ |
TCA |
√ |
√ |
√ |
√* |
√* |
√ |
half-life |
t½ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
area under the curve |
AUC |
√ |
√ |
√ |
√ |
√ |
ASC |
√ |
√ |
√ |
√ |
√ |
√ |
maximum serum concentration |
Cmax |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
minimum serum concentration |
Cmin |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
time to maximum concentration |
tmax |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
acquired immunodeficiency syndrome |
AIDS |
√ |
√ |
√ |
SIDA |
√ |
SIDA |
√ |
√ |
SIDA |
√ |
√ |
ALNÆMI |
cytomegalovirus |
CMV |
√ |
√* |
X |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
human immunodeficiency virus |
HIV |
√ |
√ |
√ |
VIH |
√ |
VIH |
√ |
√ |
VIH |
√ |
√ |
√ |
tumour necrosis factor alpha |
TNFá |
√ |
√ |
X |
X |
√ |
FNTá |
√ |
√ |
FNTá |
√ |
√ |
√ |
electrocardiogram |
ECG |
√ |
EKG |
ΗΚΓ |
√ |
EKG |
√ |
√ |
√ |
√ |
EKG |
EKG |
hjartalínurit (ECG) |
magnetic resonance imaging |
MRI |
√ |
MRT |
X |
X |
√ |
IRM |
RMI |
√ |
X |
√ |
√ |
segulómun (MRI) |
percutaneous transluminal coronary angioplasty |
PTCA |
√ |
√ |
X |
√ |
√ |
ACPT |
√ |
√ |
X |
√ |
√ |
kransæðaví kkun |
international unit |
IU |
√ |
I.E. |
√ |
UI |
√ |
UI |
UI |
IE |
UI |
IE |
IE |
a.e. |
polyvinylchloride |
PVC |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
high density polyethylene |
HDPE |
√ |
√ |
X |
√ |
√ |
PEHD |
√ |
√ |
X |
√ |
√ |
√ |
low density polyethylene |
LDPE |
√ |
√ |
X |
√ |
√ |
PEBD |
√ |
√ |
X |
√ |
√ |
√ |
New Member States:
FULL TERM |
EN |
CZ |
EE |
HU |
LV |
LT |
PL |
SK |
SL |
angiotensin converting enzyme |
ACE |
√ |
AKE |
√ |
AKE |
AKF |
• |
• |
• |
deoxyribonucleic acid |
DNA |
DNA |
√ |
DNS |
DNS |
DNR |
• |
• |
DNA |
monoamine oxidase inhibitors |
MAOI |
IMAO |
√ |
MAO-gátlók |
MAO-inhibitori |
MAO inhibitori ai |
IMAO |
IMAO |
zaviralci MAO |
volume of distribution |
Vd |
√ |
√ |
√ |
x |
Vd |
√ |
√ |
√ |
activated partial thromboplastin time |
aPTT |
√ |
√ |
aPTI |
√ |
DATL |
APTT |
√ |
X |
half-life |
t½ |
√ |
√ |
√ |
√ |
t½ |
t½, t0,5 |
√ |
√ |
area under the curve |
AUC |
√ |
√ |
√ |
√ |
AUC |
√ |
√ |
√ |
maximum serum concentration |
Cmax |
√ |
√ |
√ |
√ |
Cmax |
√ |
√ |
√ |
minimum serum concentration |
Cmin |
√ |
√ |
√ |
√ |
Cmin |
√ |
√ |
√ |
time to maximum concentration |
tmax |
√ |
√ |
√ |
√ |
tmax |
√ |
√ |
√ |
acquired immunodeficiency syndrome |
AIDS |
√ |
√ |
√ |
√ |
AIDS |
√ |
√ |
√ |
cytomegalovirus |
CMV |
√ |
√ |
√ |
√ |
CMV |
√ |
√ |
√ |
human immunodeficiency virus |
HIV |
√ |
√ |
√ |
√ |
ˇIV |
√ |
√ |
√ |
tumour necrosis factor alpha |
TNFá |
√ |
√ |
√ |
√ |
TNFį |
√ |
√ |
√ |
electrocardiogram |
ECG |
EKG |
EKG |
EKG |
EKG |
EKG |
EKG |
EKG |
EKG |
magnetic resonance imaging |
MRI |
√ |
√ |
√ |
√ |
BMR |
NMR |
NMR |
X |
percutaneous transluminal coronary angioplasty |
PTCA |
√ |
PTKA |
√ |
√ |
PTKA |
√ |
√ |
X |
international unit |
IU |
IU or m.j. |
RÜ (IU can be used) |
NE |
SV |
TV |
j.m. |
√ |
i.e. |
polyvinylchloride |
PVC |
√ |
√ |
√ |
PVH |
PVC |
PCW |
√ |
√ |
high density polyethylene |
HDPE |
√ |
√ |
√ |
ABPE |
DTPE |
√ |
√ |
√ |
low density polyethylene |
LDPE |
√ |
√ |
√ |
ZBPE |
MTPE |
√ |
√ |
√ |
√ same abbreviation as in English
X no abbreviation available in this language, use full term.
SMALL IMMEDIATE PACKAGING LABELLING ONLY
FULL TERM |
EN |
DA |
DE |
EL |
ES |
FI |
FR |
IT |
NL |
PT |
SV |
NO |
IS |
Intravenous |
IV |
i.v. |
i.v. |
√ |
√ |
√ |
√ |
e.v. |
IV/I.V./i.v./i v |
√ |
√ |
iv/IV |
i.v. |
Subcutaneous |
SC |
s.c. |
s.c. |
√ • |
X |
√ |
√ |
s.c. |
SC/S.C./s.c/sc |
√ |
√ |
sc/SC |
s.c |
Intramuscular |
IM |
i.m. |
i.m. |
√ |
√ |
√ |
√ |
i.m. |
IM/I.M./i.m./im |
√ |
√ |
im/IM |
i.m. |
New Member States:
FULL TERM |
EN |
CS |
ET |
HU |
LV |
LT |
PL |
SK |
SL |
Intravenous |
IV |
i.v. |
i.v. |
iv. |
i.v. |
i.v. |
iv. |
i.v. |
i.v. |
Subcutaneous |
SC |
s.c. |
s.c. |
sc. |
s.c. |
s.c. |
sc. |
s.c. |
s.c. |
Intramuscular |
IM |
i.m. |
i.m. |
im. |
i.m. |
i.m. |
im. |
i.m. |
i.m. |
√ same abbreviation as in English
X no abbreviation available in this language, use full term
• although not commonly used.